BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30043261)

  • 1. Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases.
    Kumar S; Karthikeyan N; Mishra S; Padmanabhan P; Radda G; Gulyás B
    Mol Neurobiol; 2019 Apr; 56(4):2559-2578. PubMed ID: 30043261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology in neurodegenerative diseases.
    Peden AH; Ironside JW
    Curr Drug Targets; 2012 Nov; 13(12):1548-59. PubMed ID: 22974397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial sequestration of misfolded proteins in neurodegenerative diseases.
    Rolli S; Sontag EM
    Biochem Soc Trans; 2022 Apr; 50(2):759-771. PubMed ID: 35311889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases.
    Giacomelli C; Daniele S; Martini C
    Biochem Pharmacol; 2017 May; 131():1-15. PubMed ID: 28159621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural animal models of neurodegenerative protein misfolding diseases.
    Moreno-Gonzalez I; Soto C
    Curr Pharm Des; 2012; 18(8):1148-58. PubMed ID: 22288404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.
    Parveen R; Shamsi TN; Fatima S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):386-395. PubMed ID: 27746352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual aspects of neurologic protein misfolding disorders.
    Pula JH; Kim J; Nichols J
    Curr Opin Ophthalmol; 2009 Nov; 20(6):482-9. PubMed ID: 19816176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.
    Upadhyay A; Amanullah A; Mishra R; Kumar A; Mishra A
    Mol Neurobiol; 2018 Feb; 55(2):1169-1182. PubMed ID: 28102469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.
    Chopra G; Shabir S; Yousuf S; Kauts S; Bhat SA; Mir AH; Singh MP
    Mol Neurobiol; 2022 Dec; 59(12):7513-7540. PubMed ID: 36205914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?
    Dubey AR; Patwa SM; Kinger S; Jagtap YA; Kumar P; Singh S; Dhiman R; Jha HC; Mishra A
    Mol Neurobiol; 2022 Jun; 59(6):3382-3401. PubMed ID: 35305242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
    Kim YJ; Takahashi R
    Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.